Evidence map›Paper›PMID 41692789›Full record

ArticleJournal of neuroinflammation2026

Intranasal SARS-CoV-2 infection changes the transcriptome of the mouse trigeminal ganglion and brainstem: potential mechanisms underlying headache and trigeminal pain presentation in COVID-19.

Jian Huang, Elodie Reboussin, Lola Bianchi, Christelle Enond, Serban Morosan, Isabelle Malet, Stéphane Fouquet, Eugénie Genestant, Frédéric Blond, William Rostène and 9 more

Abstract read
In one paragraph

Article in Journal of neuroinflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Jian HuangSorbonne Université, INSERM, CNRS, Institut de la Vision, IHU FOReSIGHT, Paris, F-75012, France.
Elodie ReboussinSorbonne Université, INSERM, CNRS, Institut de la Vision, IHU FOReSIGHT, Paris, F-75012, France.
Lola BianchiSorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Paris, F-75005, France.
Christelle EnondSorbonne Université, UMS 28, INSERM, Faculté de Médecine, Paris, F-75013, France.
Serban MorosanSorbonne Université, UMS 28, INSERM, Faculté de Médecine, Paris, F-75013, France.
Isabelle MaletSorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, (IPLESP), Paris, F-75013, France.
Stéphane FouquetSorbonne Université, INSERM, CNRS, Institut de la Vision, IHU FOReSIGHT, Paris, F-75012, France.
Eugénie GenestantSorbonne Université, INSERM, CNRS, Institut de la Vision, IHU FOReSIGHT, Paris, F-75012, France.
Frédéric BlondSorbonne Université, INSERM, CNRS, Institut de la Vision, IHU FOReSIGHT, Paris, F-75012, France.
William RostèneSorbonne Université, INSERM, CNRS, Institut de la Vision, IHU FOReSIGHT, Paris, F-75012, France.
Christophe BaudouinSorbonne Université, INSERM, CNRS, Institut de la Vision, IHU FOReSIGHT, Paris, F-75012, France.
Stéphane Melik ParsadaniantzSorbonne Université, INSERM, CNRS, Institut de la Vision, IHU FOReSIGHT, Paris, F-75012, France.
Stéphane MarotSorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, (IPLESP), Paris, F-75013, France.
Anne-Genevieve MarcelinSorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, (IPLESP), Paris, F-75013, France.
Florence CayetanotSorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Paris, F-75005, France.
Xavier Guillonneau *Sorbonne Université, INSERM, CNRS, Institut de la Vision, IHU FOReSIGHT, Paris, F-75012, France.
Laurence Bodineau *Sorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Paris, F-75005, France.
Laurence Bourgeais-Rambur *Sorbonne Université, INSERM, CNRS, Institut de la Vision, IHU FOReSIGHT, Paris, F-75012, France.
Annabelle Réaux-Le Goazigo *Sorbonne Université, INSERM, CNRS, Institut de la Vision, IHU FOReSIGHT, Paris, F-75012, France. annabelle.reaux@inserm.fr.

Funding

Agence Nationale de la Recherche ANR-RA-COVID-19-V3
6 · The paper itself

Abstract

Multiple symptoms have been observed in COVID-19 patients, including migraine and facial pain which may result from the sensitization of the trigeminal ganglion (TG) and brainstem. Recent studies suggest that SARS-CoV-2 may invade trigeminal nerve endings in the nasal cavity. However, despite these insights, the precise underlying mechanisms remain poorly understood. Here, we investigated the cellular and molecular changes in the TG and brainstem with a special attention for the spinal trigeminal nucleus in the K18-hACE2 mouse model infected with SARS-CoV-2. We first confirmed the expression of the cellular proteins playing a role in SARS-CoV-2 cell entry (ACE2, TMPRSS2, and NRP1) in both structures. We reported the expression of the viral nucleocapsid (N) and spike (S) proteins in TG and brainstem at 6 days post infection by multimodal approaches (RNAseq, RNAscope, and immunofluorescence). In the TG, S and N proteins were detected in nerve fibers as well as in TRPV1 and CGRP nociceptive neurons. Transcriptomic analyses of the TG from infected K18-hACE2 revealed significant changes in gene expression, including Ccl2, Atf3, Cxcl10, Saa3, and Plin4 genes. Additionally, increased immunoreactivity for ATF3 and Iba1 was detected in the TG of infected mice. In the brainstem, SARS-CoV-2 protein was exclusively found in neurons, with no detection in astrocytes or microglial cells, the latter exhibiting an activated form in SARS-CoV-2 mice. Bulk RNA-Seq analysis revealed a robust inflammatory response characterized by cytokine and chemokine storm, inflammasome activation (Gsdmd, Casp11, Casp1, and Nlrp3), markers of neuronal activation (Jun, Fos, Fosb), neuronal injury (Atf3), and pain-associated genes (Tacr1, Gfra1, Ntrk1, Slc17a6, Ptgs2). As found in the TG, we observed that infected neurons were found within a dense network of CGRP nociceptive nerve fibers in the trigeminal brainstem. Finally, we provided gene interaction networks and identified specific SARS-CoV-2 biomarkers Saa3, Cxcl10, Ccl2, Atf3, and Plin4 in TG and brainstem, which could serve as potential indicators of disease severity. In conclusion, this study reports a robust set of transcriptomic and cellular changes triggered by SARS-CoV-2 in the TG and brainstem, offering a potential mechanistic explanation for sensory abnormalities, such as migraine and pain, observed in COVID-19 patients.

Indexed as

Brain StemCOVID-19TranscriptomeTrigeminal GanglionTrigeminal NeuralgiaAnimalsDisease Models, AnimalMaleMiceSARS-CoV-2BiomarkerBrainstemInflammationMigraineNociceptorsPainSARS-CoV-2Sensory neuronsTrigeminal ganglion

Identifiers

PMID41692789
PMCPMC13015052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.